EUVIMEDEUVIMED entdecken
Crossref

A New Class of Hybrid Anti-inflammatory Agents of Silibinin A Modified Using Gamma Irradiation

Gyeong Han Jeong, Hanui Lee, Byung Yeoup Chung, Hyoung-Woo Bai

Chemical and Pharmaceutical Bulletin · 2025

DOI: 10.1248/cpb.c25-00040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Gyeong Han Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Division for Biotechnology, Advanced Radiation Technology Institute (ARTI), Korea Atomic Energy Research Institute (KAERI), Jeongeup 56212, …. Hauptthemen laut MEDLINE: Silymarin, Gamma Rays, Anti-Inflammatory Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silibinin is the major active constituent of the medicinal plant milk thistle seeds and possesses hepatoprotective functions. In this study, silibinin A was irradiated with gamma rays to produce 2 novel flavonolignans, silibinosins A (2) and B (3). The structures of these compounds were determined using spectroscopy and spectrometry. The anti-inflammatory effects of the flavonolignan derivatives were assessed using lipopolysaccharide (LPS)-stimulated RAW264.7 and DH82 macrophages. Silibinosin A (2) effectively suppressed the LPS-induced overproduction of pro-inflammatory mediators and cytokines in murine RAW264.7 cells. Western blot analysis revealed that compound 2 decreased the LPS-induced expression of inducible nitric oxide synthase, cyclooxygenase, and phosphorylated nuclear factor-κB and inhibitor-κBα compared to the original silibinin. Furthermore, the inhibitory effects on nitric oxide and prostaglandin E2 production were observed in LPS-stimulated DH82 canine macrophages. Our results suggest that the newly generated flavonolignans can be novel anti-inflammatory agents for use as therapeutics or ingredients in functional foods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SilymarinGamma RaysAnti-Inflammatory AgentsAnimalsMiceSilybinLipopolysaccharidesNitric OxideMacrophagesRAW 264.7 CellsDinoprostoneNitric Oxide Synthase Type IIDogsCytokinesMolecular StructureNF-kappa BCell Survival

Stichwörter der Autor:innen

RAW264.7 macrophageanti-inflammatory compoundionizing radiationring cleavagesilibinin

Substanzen

SilybinLipopolysaccharidesNitric OxideSilymarinAnti-Inflammatory AgentsDinoprostoneNitric Oxide Synthase Type IICytokinesNF-kappa B

Autor:innen und Institutionen

  • Research Division for Biotechnology, Advanced Radiation Technology Institute (ARTI), Korea Atomic Energy Research Institute (KAERI), Jeongeup 56212, Republic of Korea.
  • Center for Animal Medicine and Foods, Korea Institute of Toxicology (KIT), Jeongeup 56212, Republic of Korea.
  • Radiation Biotechnology and Applied Radioisotope Science, University of Science and Technology (UST), Daejeon 34113, Republic of Korea.

Zitieren

APA

Jeong, G. H., Lee, H., Chung, B. Y., & Bai, H. W. (2025). A New Class of Hybrid Anti-inflammatory Agents of Silibinin A Modified Using Gamma Irradiation. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00040

Vancouver

Jeong GH, Lee H, Chung BY, Bai HW. A New Class of Hybrid Anti-inflammatory Agents of Silibinin A Modified Using Gamma Irradiation. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00040

BibTeX
@article{Jeong2025,
  author = {Jeong, Gyeong Han and Lee, Hanui and Chung, Byung Yeoup and Bai, Hyoung-Woo},
  title = {A New Class of Hybrid Anti-inflammatory Agents of Silibinin A Modified Using Gamma Irradiation},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/cpb.c25-00040}
}
Kostenlos starten →